» Articles » PMID: 18372427

Cystic Fibrosis Transmembrane Conductance Regulator Controls Lung Proteasomal Degradation and Nuclear Factor-kappaB Activity in Conditions of Oxidative Stress

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2008 Mar 29
PMID 18372427
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis is a lethal inherited disorder caused by mutations in a single gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein, resulting in progressive oxidative lung damage. In this study, we evaluated the role of CFTR in the control of ubiquitin-proteasome activity and nuclear factor (NF)-kappaB/IkappaB-alpha signaling after lung oxidative stress. After a 64-hour exposure to hyperoxia-mediated oxidative stress, CFTR-deficient (cftr(-/-)) mice exhibited significantly elevated lung proteasomal activity compared with wild-type (cftr(+/+)) animals. This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha. In vitro, human CFTR-deficient lung cells exposed to oxidative stress exhibited increased proteasomal activity and decreased NF-kappaB-dependent transcriptional activity compared with CFTR-sufficient lung cells. Inhibition of the CFTR Cl(-) channel by CFTR(inh-172) in the normal bronchial immortalized cell line 16HBE14o- increased proteasomal degradation after exposure to oxidative stress. Caspase-3 inhibition by Z-DQMD in CFTR-sufficient lung cells mimicked the response profile of increased proteasomal degradation and reduced NF-kappaB activity observed in CFTR-deficient lung cells exposed to oxidative stress. Taken together, these results suggest that functional CFTR Cl(-) channel activity is crucial for regulation of lung proteasomal degradation and NF-kappaB activity in conditions of oxidative stress.

Citing Articles

The COPD-Associated Polymorphism Impairs the CFTR Function to Suppress Excessive IL-8 Production upon Environmental Pathogen Exposure.

Hinata D, Fukuda R, Okiyoneda T Int J Mol Sci. 2023; 24(3).

PMID: 36768629 PMC: 9916815. DOI: 10.3390/ijms24032305.


Cystic Fibrosis: Systems Biology Analysis from Homozygous p.Phe508del Variant Patients' Samples Reveals Perturbations in Tissue-Specific Pathways.

Poloni J, Rispoli T, Rossetti M, Trindade C, Vargas J Biomed Res Int. 2021; 2021:5262000.

PMID: 34901273 PMC: 8660202. DOI: 10.1155/2021/5262000.


CFTR Regulates the Proliferation, Migration and Invasion of Cervical Cancer Cells by Inhibiting the NF-κB Signalling Pathway.

Wu Z, Li J, Zhang Y, Hu L, Peng X Cancer Manag Res. 2020; 12:4685-4697.

PMID: 32606960 PMC: 7308183. DOI: 10.2147/CMAR.S252296.


Oxidative stress, autophagy and airway ion transport.

OGrady S Am J Physiol Cell Physiol. 2018; 316(1):C16-C32.

PMID: 30303690 PMC: 6383147. DOI: 10.1152/ajpcell.00341.2018.


Cystic fibrosis: a mucosal immunodeficiency syndrome.

Cohen T, Prince A Nat Med. 2012; 18(4):509-19.

PMID: 22481418 PMC: 3577071. DOI: 10.1038/nm.2715.


References
1.
Stutts M, Canessa C, Olsen J, Hamrick M, Cohn J, Rossier B . CFTR as a cAMP-dependent regulator of sodium channels. Science. 1995; 269(5225):847-50. DOI: 10.1126/science.7543698. View

2.
Venkatakrishnan A, Stecenko A, King G, Blackwell T, Brigham K, Christman J . Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol. 2000; 23(3):396-403. DOI: 10.1165/ajrcmb.23.3.3949. View

3.
Pollard H, Ji X, Jozwik C, Jacobowitz D . High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics. 2005; 5(8):2210-26. DOI: 10.1002/pmic.200401120. View

4.
Denning G, Anderson M, Amara J, Marshall J, Smith A, Welsh M . Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992; 358(6389):761-4. DOI: 10.1038/358761a0. View

5.
Han Y, Weinman S, Boldogh I, Walker R, Brasier A . Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. J Biol Chem. 1999; 274(2):787-94. DOI: 10.1074/jbc.274.2.787. View